Mendel Partners Ltd

Mendel Partners help Advanced Therapies and Rare Disease Biotech clients across the globe to attract best-in-class investors & leadership teams that make meaningful differences to patients & shareholders alike. Our exclusive commitment to the small but rapidly emerging cell & gene therapy and rare diseases sector means our clients gain access to the limited number of business-critical experts that cannot otherwise be found through more traditional search practices. For our start-up clients currently operating with little or no capital, we have also developed some completely unique fee models that enable them to attract business-critical expertise and funding, without the huge reimbursement costs usually associated with doing so. We can help you recruit; Chairperson NED Board Advisors C-Suite President/VPs Strategic Directors General Managers Managing Directors Business Unit Head Leveraging our expert knowledge within this space, alongside our especially developed Advanced Therapies and Rare Disease focused Leadership portfolio, deep research-led recruitment methods and highly personalised sourcing tactics; we can help you recruit boards and leadership teams that will make the most meaningful impact to your business, and the patients and shareholders you serve.